. would like to submit the financial statements and information on the performance of the Company and subsidiary companies in Q2/2019 to The Stock Exchange of Thailand as follows: L.P.N. Development Public
1,662.64 million baht as vary from increase in trade accounts payable and other payables of 34.63 Million Baht, short term loan to personnel and related company of 20.00 Million Baht, short term loan from
์ - 34-0135 www.interpharma.co.th Inter Pharma Public Company Limited 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawongse, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135
Consolidated Financial Results for The Year 2019 For the year ended December 31st, 2019 Consolidated Profit & Loss of Global Consumer Public Company Limited Unit: Million Baht Y 2019 Y 2018 Change %YoY Revenues
/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
provides services. Page 2 of 7 Table summarized the operating results of the Group (unit : Bt million) This situation significantly affects the Company and its subsidiaries’ business activities in terms of
(Translation) th August, Ref: SET-- Re: Management's Discussion and Analysis and Operating Results for Quarter / Dear: The President The Stock Exchange of Thailand Filter Vision Public Company
of liabilities not exceeding the shareholders’ equity of the securities company ; (b) financing lease which is under the condition allowing for early termination of lease by the securities company as
Microsoft Word - MD&A.EN (Revised 3) (1) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดัสมุทรสาคร 74000 111 Moo 2 TambonThachin, Amphurmuangsamutsakhon
of Shares of Trans.Ad Solutions Co., Ltd. (Added) Attention: Director and Manager The Stock Exchange of Thailand (SET) The Board of Directors’ meeting of Nation International Edutainment Public Company